Congestive heart failure (CHF) is a chronic, progressive condition that affects the heart's ability to pump blood efficiently enough to meet the body’s needs, either by becoming too weak or too stiff and unable to fill with blood. This can be caused by a variety of factors - most notably coronary artery disease, cardiomyopathy, arrhythmia, and high blood pressure.
In the US, CHF affects approximately 6.5 million people, and directly accounts for 8.5% of all heart disease deaths. This figure continues to grow with nearly 1 million new cases and hospitalizations each year. As this trend progresses, costs are predicted to reach $69.8 billion (127% increase from 2012) by 2030
Diagnostic Robotics’ Intelligent Care Journeys empowers health plans and risk-bearing providers to proactively identify and treat CHF patients with actionable insights, leveraging vast external data to deliver personalized next steps for every patient.
Reduce CHF Care Costs with Early Identification & Treatment
Per engaged patient in a with a large national health plan to target a site of care education campaign
For patients identified by Diagnostic Robotics solutions
Per contacted patient when compared to those identified from the plans Transitions of Care (TOC) list
Proactive intervention stops preventable CHF care cost escalations
78 years old, FemaleThe model detected an ED visit due to UTI followed by deterioration of the kidney disease. In addition, the model identified sudden non-adherence to diabetes medication, indicating change in patient normal behavior pattern.
Lower costs by preventing CHF exacerbation
Understand why your patients are at risk and recommend next steps for care based on the main risk factors based on their impact on future risk and costs